6Vasilevskaya LS, Stan Eya, Chernikov MP & Shlygin GK. Inhibitory action of glycomacropeptide produced on the gastric secretion by various humoral stimulants. FEMS Microbiology Letters, 1997, 43: 21 - 24.
7Faure J-C,Schellenberg DA,Bexter A & Wuerzner HP. Barrier effect of Bifidobacterium longum on a pathogenic Escherichia coli strain by gut colonization in the germ-free eat. Zeitschrift fur Ernahrungswissenschaft, 1984, 23:41 - 51.
8Azuma SG. The effect of chymosin on kappa-casein-coated polystyrene latex particles and bovine casein micelles. International Dairy Journal, 7: 553- 558.
9Kawasaki Y, Isoda H, Tanimoto M & Ahiko K. Inhibition by lactoferin and k-casein glycomacropeptide of binding of cholera toxin to its receptor. Bioscience, Biotechnology and Biochemistry, 1992,56:195-198.
10Waugh D F and Von Hippel PH. J. Am. Chem, 1956, 78: 4576-4582.
5David F, Waugh, Peter H. κ-Casein and the stabilization of casein micelles [J] . American Chemical Society, 1956, 78 (18) : 4 576-4 582.
6Saito T, Yamajji A, Itoh T. A new isolation method of ca- seinoglycopeptide from sweet cheese whey [J] . Dairy Sci- ence, 1991, 174 (6) : 2 831-2 837.
7Kawasaki Yoshihiro, Dosako Shunichi. Process of produc- ing K-casein glyeomacropeptides: United States Patent, 5278288 [P]. 1994.
8Ernest P, Brody. Biological activities of bovine glyco- macropeptide [J]. British Journalof Nutrition, 2000, 84 (1) : 39-46.
9Manso M A, LoPez Falldino R. Angiotensin I converting enzyme-inhibitory activity of bovine, ovine and caprine K- casein macropeptides and their tryptie hydrolyzates [J] . J Food Prot, 2003, 66 (9): 1 686-1 692.
